Open Access
Issue
MATEC Web of Conferences
Volume 60, 2016
2016 3rd International Conference on Chemical and Biological Sciences
Article Number 03002
Number of page(s) 5
Section Applied Chemistry
DOI https://doi.org/10.1051/matecconf/20166003002
Published online 08 June 2016
  1. María L. Cuestas & Verónica L. Mathet. Drug delivery systems and liver targeting for improved pharmacotherapy of the Hepatitis B virus (HBV) infection. Pharm Res, 27, 1184–1202 (2010) [CrossRef]
  2. Su-zhen Jiang, Jia-jia Zheng. Hepatitis B Virus S Promoter Deletionin Hepatocellular Carcinoma. Infection Inte national, 1, 14-23 (2012)
  3. Hepatitis B. World Health Organization. World Health Org. 204 (2012)
  4. Park NH, Song IH. Chronic hepatitis B in hepatocarcinogenesis.Pos. Med J, 82(970), 507–515.(2006)
  5. Westland C, Delandy W. Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil.Gas, 125(1), 107-116 (2003) [CrossRef]
  6. Wright TL.Introduction to chronic hepatitis B infection.Am J Gastl, 101, 1-6 (2006) [CrossRef]
  7. Ceen-Ming Tang, Tung On Yau. Management of chronic hepatitis B infection: Currenttreatment guidelines, challenges, and new developmentsWorld J Gastroenterol, 20(20), 6262-6278 (2014) [CrossRef]
  8. Han YX, Xue R,Zhao W. Antiviral therapertic efficacy of foscamet inhepatitis B virus infection. Antiv Res, 68(3), 147-153 (2005) [CrossRef]
  9. Shin MS, Kang EH. A flavonoid from medicinal plants blocks hepatitis Bvirus-e antigen secretion in HBV-infected hepatocytes. Antiv Res, 67(3), 163–168 (2005) [CrossRef]
  10. Zembower DE, Lin YM. Robustaflavone, a potential non-nucleoside anti-hepatitis B agent. Antiv Res, 39(2),81-88 (1998) [CrossRef]
  11. Zhou Z,Zhang Y,Ding XR. Protocatechuic aldehyde inhibits hepatitis Bvirus replication both in vitro and in vivo. Antiv Res, 74(1), 59–64 (2007) [CrossRef]
  12. Addison WR, Wong WW. A quantitative competitive PCR assay for thecovalently closed circular form of the duck hepatitis B virus. Antiv Res, 48(l), 27-37 (2000) [CrossRef]
  13. Le Guerhier F, Thermet A. Antiviral effect of adefovir in combination with aDNA vaccine in the duck hepatitis B virus infection model.J. Hepa, 38(3), 328-334 (2003) [CrossRef]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.